Form 483

Cosway Company, Inc. Form 483, 2017-03-10

FDA issued a Form 483 to Cosway Company, Inc. on 2017-03-10 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

Cosway Company, Inc. · Carson, United States · Issued March 10, 2017

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

10 Mar 2017
21 CFR 211.100(a)

Approval and review of procedures

Cited by Stephanie A Slater

10 Mar 2017
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Stephanie A Slater

10 Mar 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Stephanie A Slater

10 Mar 2017
21 CFR 211.166(a)

Lack of written stability program

Cited by Stephanie A Slater

10 Mar 2017
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Stephanie A Slater

Inspected site

CCCosway Company, Inc.Carson, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 9 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere